#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pseudomyxoma peritonei Encephalitis autoimmune Ischaemic stroke Spinal cord injury Crohn's disease Thrombotic microangiopathy Neurodevelopmental disorder Acquired ATTR amyloidosis Mantle cell lymphoma Arterial tortuosity syndrome Immunodeficiency Retinoblastoma Anal cancer Palmoplantar pustulosis Rett syndrome More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Treatment Adrenocortical carcinoma Prolymphocytic leukaemia – Basic Information Alagille syndrome – Basic Information Antithrombin III deficiency – Life with Disease Leiomyosarcoma metastatic Nephrotic syndrome – Life with Disease Glycogen storage disease type II – Basic Information Skin angiosarcoma – Trials in Disease Rhabdoid tumour – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Palivizumab Gen1053 Peposertib Canakinumab Topotecan GAXILOSE Acalabrutinib Afamelanotide Mycophenolic Acid Alclometasone Dipropionate Tacrolimus Bilastine F510/08 Potassium Iodide Clindamycin Phosphate Diltiazem Hydrochloride Lymecycline Polydextrose Acoramidis Hydrochloride Deferoxamine More therapies…

    Learn about Your Condition

    Diabetes insipidus Rectal adenocarcinoma Labour induction Brain cancer metastatic Fibrous dysplasia of bone Pulmonary resection Lennox-Gastaut syndrome Carotid arteriosclerosis Nephrolithiasis Primary hyperaldosteronism Hypotension Acoustic neuroma Bronchiolitis Laryngeal cancer Myelofibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Coronary artery disease

  • A Study of Intravenous Lidocaine to Reduce Inflammation in Patients Undergoing Heart Valve or Coronary Artery Bypass Surgery with Heart-Lung Machine

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac valve disease
    • Coronary artery disease
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    Spain

  • Study of dapagliflozin and semaglutide to reverse prediabetes to normal blood sugar levels in patients with coronary artery disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    • Coronary artery disease
    Investigated Drugs:
    • Dapagliflozin
    • Semaglutide
    Denmark

  • Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    • Coronary artery disease
    Investigated Drugs:
    • Prasugrel
    • Acetylsalicylic Acid
    Poland

  • Study on the Effects of Ticagrelor and Acetylsalicylic Acid in Patients with Coronary Artery Disease Undergoing CABG Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Acetylsalicylic Acid Ph. Eur.
    • Acetylsalicylic Acid
    • Ticagrelor
    Austria Germany Sweden

  • Study on the Effects of Oxycodone and Paracetamol in Patients with Heart Valve or Coronary Artery Disease After Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic valve disease
    • Mitral valve disease
    • Tricuspid valve disease
    Investigated Drugs:
    • Oxycodone Hydrochloride
    • Paracetamol
    Finland

  • Study on the Effects of Semaglutide, Dapagliflozin, and Metformin in Patients with Coronary Artery Disease and Prediabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    • Glucose tolerance impaired
    • Coronary artery disease
    Investigated Drugs:
    • Metformin Hydrochloride
    • Dapagliflozin
    • Semaglutide
    Poland
1 2 3 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!